NCT01468844View on ClinicalTrials.gov

Minocycline to Treat Central Retinal Vein Occlusion

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 21, 2011

Primary Completion Date

March 4, 2015

Study Completion Date

May 13, 2015

Conditions
Retinal Vein Occlusion
Interventions
DRUG

Minocycline

100 mg pink opaque capsule

DRUG

Placebo

Placebo

DRUG

Bevacizumab

1.25 mg bevacizumab injection

Trial Locations (2)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

Unknown

Bristol Eye Hospital, Bristol

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT01468844 - Minocycline to Treat Central Retinal Vein Occlusion | Biotech Hunter | Biotech Hunter